National Penn Investors Trust’s Gilead Sciences GILD Stock Holding History

National Penn Investors Trust’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$12M	Sell	130,165 -4,596	-3%	-$414K	1.39%	29
2015 Q4	$13.6M	Sell	134,761 -6,824	-5%	-$710K	1.53%	26
2015 Q3	$13.9M	Buy	+141,585	New	+$15.7M	1.61%	25
2015 Q1	–	Sell	-4,629	Closed	-$437K	–	228
2014 Q4	$437K	Buy	4,629 +144	+3%	+$14.9K	0.05%	130
2014 Q3	$477K	Buy	4,485 +85	+2%	+$8.32K	0.06%	129
2014 Q2	$365K	Hold	4,400	–	–	0.04%	141
2014 Q1	$312K	Sell	4,400 -70	-2%	-$5.49K	0.04%	153
2013 Q4	$335K	Buy	4,470 +70	+2%	+$4.87K	0.04%	174
2013 Q3	$277K	Hold	4,400	–	–	0.03%	180
2013 Q2	$226K	Buy	+4,400	New	+$229K	0.03%	191

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

National Penn Investors Trust's GILD Position: Q1 2016 in Review

National Penn Investors Trust reduced its Gilead Sciences (GILD) stake by 3.4% in Q1 2016, selling an estimated $414K and leaving 130,165 shares worth $12M. The position accounts for 1.39% of the portfolio, ranked #29.

National Penn Investors Trust first reported a position in GILD in Q2 2013 and has held it in 10 quarters since. The position peaked at $13.9M in Q3 2015. 1,630 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

National Penn Investors Trust held 130,165 shares of Gilead Sciences worth $12M as of Q1 2016.
National Penn Investors Trust sold 4,596 Gilead Sciences shares in Q1 2016, an estimated $414K.
Gilead Sciences made up 1.39% of National Penn Investors Trust's portfolio in Q1 2016, its #29 holding.
National Penn Investors Trust first reported a position in Gilead Sciences in Q2 2013 and has held it in 10 quarters since.
National Penn Investors Trust's Gilead Sciences position peaked at $13.9M in Q3 2015.
1,630 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on National Penn Investors Trust's 13F filing for Q1 2016, filed 11 May 2016.